Poiani G J, Riley D J, Fox J D, Kemnitzer J E, Gean K F, Kohn J
Department of Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway 08854-5635.
Bioconjug Chem. 1994 Nov-Dec;5(6):621-30. doi: 10.1021/bc00030a018.
Synthetic approaches for the preparation of macromolecular conjugates of the antifibrotic agent cis-4-hydroxy-L-proline (cHyp) were explored, and the efficacy of the conjugates in inhibiting collagen accumulation was investigated in vitro and in vivo. In one approach, poly(PEG-Lys), an alternating copolymer of poly(ethylene glycol) (PEG) and lysine, was used as the carrier. To prepare pendent chain systems, cHyp was attached to poly(PEG-Lys) through an amide linkage [poly(PEG-Lys-cHyp amide)] or through an ester linkage [poly(PEG-Lys-cHyp ester)]. In an alternative approach, cHyp was incorporated into the backbone of a linear copolymer consisting of PEG, succinic acid, and cHyp units [poly(PEG-succinate-cHyp)]. Bioactivity in vitro was assessed by the ability of the cHyp conjugates to inhibit growth of cultured smooth muscle cells (SMC) and rat lung fibroblasts (RLF). Cell numbers were compared to control experiments in the presence of biologically inactive trans-4-hydroxy-L-proline (tHyp). After a 5 day period, the presence of 8 micrograms/mL of cHyp delivered by poly(PEG-Lys-cHyp amide) resulted in a 47% reduction in the number of SMC (p < 0.05), the presence of 36 micrograms/mL of cHyp delivered by poly(PEG-Lys-cHyp ester) resulted in a 38% reduction in the number of SMC (p < 0.05), while the presence of 118 micrograms/mL of cHyp delivered by poly(PEG-succinate-cHyp) resulted in a 31% reduction in the number of cells (p < 0.05). An identical trend was observed for the inhibition of RLF growth. In general, poly(PEG-Lys-cHyp amide) was most active, followed by poly(PEG-Lys-cHyp ester) and the backbone system, poly(PEG-succinate-cHyp). Specifically, poly(PEG-Lys-cHyp amide) was over 100-fold more active in inhibiting cell growth than free cHyp. Bioactivity in vivo was evaluated by measuring collagen accumulation in subcutaneously implanted poly(vinyl alcohol) sponges in rats. Among the tested conjugates, poly(PEG-Lys-cHyp amide) was most active, reducing collagen accumulation in the sponge by 33% after 14 days relative to controls (p < 0.05). This result indicates that the covalent attachment of cHyp to poly(PEG-Lys) carries may be a useful strategy for the local inhibition of collagen accumulation in tissues.
探索了制备抗纤维化剂顺式-4-羟基-L-脯氨酸(cHyp)大分子缀合物的合成方法,并在体外和体内研究了这些缀合物抑制胶原蛋白积累的功效。在一种方法中,聚(PEG-赖氨酸),即聚乙二醇(PEG)和赖氨酸的交替共聚物,被用作载体。为了制备侧链系统,cHyp通过酰胺键[聚(PEG-Lys-cHyp酰胺)]或酯键[聚(PEG-Lys-cHyp酯)]连接到聚(PEG-赖氨酸)上。在另一种方法中,cHyp被并入由PEG、琥珀酸和cHyp单元组成的线性共聚物的主链中[聚(PEG-琥珀酸酯-cHyp)]。通过cHyp缀合物抑制培养的平滑肌细胞(SMC)和大鼠肺成纤维细胞(RLF)生长的能力来评估体外生物活性。将细胞数量与在存在无生物活性的反式-4-羟基-L-脯氨酸(tHyp)的对照实验中进行比较。在5天的时间段后,聚(PEG-Lys-cHyp酰胺)递送的8微克/毫升cHyp的存在导致SMC数量减少47%(p < 0.05),聚(PEG-Lys-cHyp酯)递送的36微克/毫升cHyp的存在导致SMC数量减少38%(p < 0.05),而聚(PEG-琥珀酸酯-cHyp)递送的118微克/毫升cHyp的存在导致细胞数量减少31%(p < 0.05)。对于RLF生长的抑制观察到相同的趋势。一般来说,聚(PEG-Lys-cHyp酰胺)最具活性,其次是聚(PEG-Lys-cHyp酯)和主链系统聚(PEG-琥珀酸酯-cHyp)。具体而言,聚(PEG-Lys-cHyp酰胺)在抑制细胞生长方面的活性比游离cHyp高100倍以上。通过测量大鼠皮下植入的聚乙烯醇海绵中的胶原蛋白积累来评估体内生物活性。在测试的缀合物中,聚(PEG-Lys-cHyp酰胺)最具活性,相对于对照组,14天后海绵中的胶原蛋白积累减少了33%(p < 0.05)。该结果表明,将cHyp共价连接到聚(PEG-赖氨酸)载体上可能是局部抑制组织中胶原蛋白积累的一种有用策略。